Acute injection and chronic perfusion of kisspeptin elicit gonadotropins release but fail to trigger ovulation in the mare.
Abstract: Kisspeptin has emerged as the most potent gonadotropin-releasing hormone (GnRH) secretagogue and appears to represent the penultimate step in the central control of reproduction. In the sheep, we showed that kisspeptin could be used to manipulate gonadotropin secretion and control ovulation. Prompted by these results, we decided to investigate whether kisspeptin could be used as an ovulation-inducing agent in another photoperiodic domestic mammal, the horse. Equine kisspeptin-10 (eKp10) was administered intravenously as bolus injections or short- to long-term perfusions to Welsh pony mares, either during the anestrus season or at various stages of the cycle during the breeding season. In all the experimental conditions, eKp10 reliably increased peripheral concentrations of both luteinizing hormone and follicle-stimulating hormone. The nature of the response to eKp10 was consistent across experimental conditions and physiological states: the increase in gonadotropins was always rapid and essentially transient even when eKp10 was perfused for prolonged periods. Furthermore, eKp10 consistently failed to induce ovulation in the mare. To gain insights into the underlying mechanisms, we used acute injections or perfusions of GnRH. We also cloned the equine orthologues of the kisspeptin precursor and Kiss1r; this was justified by the facts that the current equine genome assembly predicted an amino acid difference between eKp10 and Kp10 in other species while an equine orthologue for Kiss1r was missing altogether. In light of these findings, potential reasons for the divergence in the response to kisspeptin between ewe and mare are discussed. Our data highlight that kisspeptin is not a universal ovulation-inducing agent.
Publication Date: 2014-02-20 PubMed ID: 24429215DOI: 10.1095/biolreprod.113.114157Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research investigates the effect of a hormone called kisspeptin on inducing ovulation in mares after it showed promise in sheep. The study found that although kisspeptin increased levels of certain gonadotropins – hormones that stimulate the ovaries – it was not effective in triggering ovulation in mares.
Experiment and results
- Scientists carried out this research on Welsh pony mares to understand if kisspeptin – specifically its variant equine kisspeptin-10 (eKp10) – could be used to control ovulation similar to how it worked in sheep.
- eKp10 was administered to the ponies via direct injection or perfusion. This was done during the anestrus season (when females aren’t sexually receptive) and across different stages of the reproductive cycle during the breeding season.
- The treatment with eKp10 led to increased levels of luteinizing hormone and follicle-stimulating hormone – the two main gonadotropins – in all tested conditions and stages. These hormones are crucial for the development and release of eggs from the ovary.
- However, despite the increase in gonadotropin levels, eKp10 did not trigger ovulation in the mares.
Further Investigation
- To understand the mechanisms behind eKp10’s failure to stimulate ovulation, the researchers used acute injections or perfusions of gonadotropin-releasing hormone (GnRH).
- The researchers cloned the equine versions of the kisspeptin precursor and Kiss1r because the horse genome differs from other species regarding eKp10 and Kp10; also, the horse genome was missing an equine version of Kiss1r.
Implications
- The study’s findings showed that kisspeptin did not have a universal application as an ovulation-inducing agent as it failed to initiate ovulation in mares despite increasing gonadotropin levels.
- This suggests that the hormone’s effect differs between species, and the ability to control reproduction using kisspeptin would need specific research for each species.
- The lack of efficacy in triggering horse ovulation is also considered important for developing more understanding of kisspeptin’s role in animal reproduction.
Cite This Article
APA
Decourt C, Caraty A, Briant C, Guillaume D, Lomet D, Chesneau D, Lardic L, Duchamp G, Reigner F, Monget P, Dufourny L, Beltramo M, Dardente H.
(2014).
Acute injection and chronic perfusion of kisspeptin elicit gonadotropins release but fail to trigger ovulation in the mare.
Biol Reprod, 90(2), 36.
https://doi.org/10.1095/biolreprod.113.114157 Publication
Researcher Affiliations
- INRA, UMR85 Physiologie de la Reproduction et des Comportements, CNRS, Université François Rabelais de Tours, IFCE, Nouzilly, France.
MeSH Terms
- Animals
- Cloning, Molecular
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Gonadotropins / metabolism
- Horses / physiology
- Kisspeptins / administration & dosage
- Kisspeptins / genetics
- Kisspeptins / metabolism
- Ovulation / drug effects
- Ovulation Induction / methods
- Ovulation Induction / veterinary
- Receptors, G-Protein-Coupled / genetics
- Receptors, G-Protein-Coupled / isolation & purification
- Treatment Failure
Citations
This article has been cited 4 times.- Nestor CC, Merkley CM, Lehman MN, Hileman SM, Goodman RL. KNDy neurons as the GnRH pulse generator: Recent studies in ruminants. Peptides 2023 Jun;164:171005.
- Leonardi CEP, Carrasco RA, Dias FCF, Zwiefelhofer EM, Adams GP, Singh J. Mechanism of LH release after peripheral administration of kisspeptin in cattle. PLoS One 2022;17(12):e0278564.
- Kwong GPS, Klein C. Deslorelin and naltrexone stimulate follicular development in mares during autumn transition and early anestrus. Can Vet J 2019 Aug;60(8):855-858.
- Kanai N, Endo N, Ohkura S, Wakabayashi Y, Matsui H, Matsumoto H, Ishikawa K, Tanaka A, Watanabe T, Okamura H, Tanaka T. An administration of TAK-683 at a minimally effective dose for luteinizing hormone stimulation under the absence of the ovary induces luteinizing hormone surge in ovary-intact goats. J Reprod Dev 2017 Jun 21;63(3):305-310.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists